ArticleContemporary oncology (Poznan, Poland)2023
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure.
Bożena Sikora-Kupis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.